PharmaBoardroom

Adrian van den Hoven – Director General, Medicines for…

Over the last ten years, generic medicines have increased access to medicines by over 100% in 7 key therapeutic areas and have provided massive…

Healthcare Politics in 2019

Aditya Bhattacharji manages Eurasia Group‘s healthcare analysis. In this article, he gives his predictions for the political landscape in…

Top Pharma Markets in Europe Ranking (2016)

The Top Pharma Markets in Europe for 2016 according to the latest EFPIA figures. Germany leads the way, with a market size of EUR 30.815 billion,…

The Long and Short of Drug Shortages in America

Chester “Chip” Davis, Jr, the President and CEO of the Association for Accessible Medicines (AAM) weighs in on the issue of drug shortages in…

Orphan Drugs in Europe: A Snapshot

125 medicines for rare diseases were approved by the EMA between 2004 and 2014, of which 71 were granted orphan drug status. This chart shows the…

Precision Medicine Needs Global Genetic Data

Axel Schumacher, co-founder and chief scientific officer of Shivom, a data-driven next generation precision-medicine company in the blockchain space,…

How do we Encourage Patients to Continue Taking their Medicines?

David Peña Castillo, president and founder of the Mexican Federation of Rare Diseases (FEMEXER), addresses the problem of patients deserting…

10 Articles From Our Contributors You Should Read from 2018

In 2018 we started approaching thought leaders across the life sciences sector to contribute their opinions and insights and provide valuable insider…